Evidence map›Paper›PMID 32083297›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2020

Variability in Action Selection Relates to Striatal Dopamine 2/3 Receptor Availability in Humans: A PET Neuroimaging Study Using Reinforcement Learning and Active Inference Models.

Rick A Adams, Michael Moutoussis, Matthew M Nour, Tarik Dahoun, Declan Lewis, Benjamin Illingworth, Mattia Veronese, Christoph Mathys, Lieke de Boer, Marc Guitart-Masip and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Rick A AdamsInstitute of Cognitive Neuroscience, University College London, London WC1N 3AZ, UK.
Michael MoutoussisWellcome Centre for Human Neuroimaging, University College London, London WC1N 3BG, UK.
Matthew M NourPsychiatric Imaging Group, Robert Steiner MRI Unit, MRC London Institute of Medical Sciences, Hammersmith Hospital, London W12 0NN, UK.
Tarik DahounPsychiatric Imaging Group, Robert Steiner MRI Unit, MRC London Institute of Medical Sciences, Hammersmith Hospital, London W12 0NN, UK.
Declan LewisInstitute of Cognitive Neuroscience, University College London, London WC1N 3AZ, UK.
Benjamin IllingworthInstitute of Cognitive Neuroscience, University College London, London WC1N 3AZ, UK.
Mattia VeroneseCentre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London SE5 8AF, UK.
Christoph MathysMax Planck-UCL Centre for Computational Psychiatry and Ageing Research, London WC1B 5EH, UK.
Lieke de BoerAging Research Center, Karolinska Institute, 171 65 Stockholm, Sweden.
Marc Guitart-MasipMax Planck-UCL Centre for Computational Psychiatry and Ageing Research, London WC1B 5EH, UK.
Karl J FristonWellcome Centre for Human Neuroimaging, University College London, London WC1N 3BG, UK.
Oliver D HowesPsychiatric Imaging Group, Robert Steiner MRI Unit, MRC London Institute of Medical Sciences, Hammersmith Hospital, London W12 0NN, UK.
Jonathan P RoiserInstitute of Cognitive Neuroscience, University College London, London WC1N 3AZ, UK.
University College London · GBImperial College London · GBKarolinska Institutet · SEKing's College London · GBScuola Internazionale Superiore di Studi Avanzati · ITWellcome Centre for Human Neuroimaging · GB

Funding

Medical Research Council G0700995Medical Research Council MC_U120097115Medical Research Council MR/L022176/1Medical Research Council MR/N026063/1Medical Research Council MR/N027078/1Medical Research Council MR/S007806/1Wellcome TrustWellcome Trust 088130/Z/09/ZWellcome Trust 094849/Z/10/ZWellcome Trust 095844/7/11/Z
6 · The paper itself

Abstract

Choosing actions that result in advantageous outcomes is a fundamental function of nervous systems. All computational decision-making models contain a mechanism that controls the variability of (or confidence in) action selection, but its neural implementation is unclear-especially in humans. We investigated this mechanism using two influential decision-making frameworks: active inference (AI) and reinforcement learning (RL). In AI, the precision (inverse variance) of beliefs about policies controls action selection variability-similar to decision 'noise' parameters in RL-and is thought to be encoded by striatal dopamine signaling. We tested this hypothesis by administering a 'go/no-go' task to 75 healthy participants, and measuring striatal dopamine 2/3 receptor (D2/3R) availability in a subset (n = 25) using [11C]-(+)-PHNO positron emission tomography. In behavioral model comparison, RL performed best across the whole group but AI performed best in participants performing above chance levels. Limbic striatal D2/3R availability had linear relationships with AI policy precision (P = 0.029) as well as with RL irreducible decision 'noise' (P = 0.020), and this relationship with D2/3R availability was confirmed with a 'decision stochasticity' factor that aggregated across both models (P = 0.0006). These findings are consistent with occupancy of inhibitory striatal D2/3Rs decreasing the variability of action selection in humans.

Indexed as

Reinforcement, PsychologyAdultBayes TheoremChoice BehaviorDecision MakingDopamine AgonistsFemaleHumansLearningMaleNeostriatumOxazinesPositron-Emission TomographyReceptors, Dopamine D2Receptors, Dopamine D3Young AdultDopamine AgonistsDRD2 protein, humanDRD3 protein, humannaxagolideOxazinesReceptors, Dopamine D2Receptors, Dopamine D3action selectionactive inferencedecision temperaturedopamine 2/3 receptorsgo no-go taskreinforcement learning

Identifiers

PMID32083297
PMCPMC7233027
OpenAlexW3005552318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.